Currently, Beta Bionics Inc [BBNX] is trading at $13.95, down -6.44%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BBNX shares have gain 17.92% over the last week, with a monthly amount glided 18.12%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Beta Bionics Inc [NASDAQ: BBNX] stock has seen the most recent analyst activity on February 24, 2025, when Stifel initiated its Buy rating and assigned the stock a price target of $25. Previously, Piper Sandler started tracking the stock with Overweight rating on February 24, 2025, and set its price target to $26. On February 24, 2025, Leerink Partners initiated with a Outperform rating and assigned a price target of $28 on the stock. Lake Street started tracking the stock assigning a Buy rating and suggested a price target of $30 on February 24, 2025. BofA Securities initiated its recommendation with a Buy. Robert W. Baird started tracking with a Neutral rating for this stock on February 20, 2025, and assigned it a price target of $20. In a note dated February 20, 2025, Ladenburg Thalmann initiated an Neutral rating and provided a target price of $20 on this stock.
This stock has fluctuated between a low of $8.89 and a high of $24.50 over the last 52 weeks. Beta Bionics Inc [NASDAQ: BBNX] shares were valued at $13.95 at the most recent close of the market.
Analyzing the BBNX fundamentals
Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at -0.65%, Pretax Profit Margin comes in at -0.75%, and Net Profit Margin reading is -0.75%. To continue investigating profitability, this company’s Return on Assets is posted at -0.19, Equity is -0.51 and Total Capital is -0.19. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.06 points at the first support level, and at 12.17 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.92, and for the 2nd resistance point, it is at 15.90.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Beta Bionics Inc [NASDAQ:BBNX] is 15.88. As well, the Quick Ratio is 14.93, while the Cash Ratio is 1.44.
Transactions by insiders
Recent insider trading involved Mensinger Mike, Chief Product Officer, that happened on Jan 31 ’25 when 33350.0 shares were purchased. Chief Product Officer, Mensinger Mike completed a deal on Jan 31 ’25 to sell 13.0 shares. Meanwhile, 10% Owner Wellington Hadley Harbor Aggre bought 1.0 million shares on Jan 31 ’25.
